Gapping up
In reaction to strong earnings/guidance:
- MOH +18.6%, TCS +14.6%, P +14.5% (also upgraded to Outperform from Sector Perform at RBC Capital Mkts), SODA +14.5%, GLUU +10.5%, CAI +10%, SEND +9.7%, QGEN +8.8% (also announced that its careHPV Test, one of the only molecular diagnostics for high-risk human papillomavirus designed to screen women in low-resource settings, has been added to the World Health Organization list of prequalified in vitro diagnostics), PAYC +8.2%, ZEN +7.6%, HURN +6.6%, NBIX +6.5%, WIRE +6.3%, MTSI +5.6%, NANO +4.2%, AAPL +4.1%, ICL +4%, OLN +3.4%, GNRC +3.3%, BAND +3.1%, SSYS +3% (light volume), GRMN +2.9% (light volume), COHR +2.4%, MT +2.4%, CACC +2.2% (light volume), VRSK +2.2%, ENLK +2.1% (light volume), SKT +2.1% (light volume), AMC +2.1%, AMRN +2%, STAG +1.9% (light volume), GNW +1.7%, HUM +1.5%, PBI +1.4%, LADR +1.3%, ZIXI +1.1% (also plans to sell France based IT value added reseller business to Bechtle AG for an enterprise value of $246 million), NFX +1% (light volume), MTOR +1%
Apple suppliers are trading higher:
- CRUS +2.4%, FNSR +2.4%, IIVI +2%, LITE +1.6%, SWKS +1.5%, QRVO +0.7%, AVGO +0.7%
Other news:
- SRG +8.4% (has entered into a $2.0 billion term loan facility with Berkshire Hathaway Life Insurance)
- TTM +4.9% (rebounding from earnings)
- CPB +4.8% (WSJ reporting that activist Third Point has built stake)
- PII +0.7% (CEO disclosed the purchase of ~3K shares worth ~$312K and 3 Directors disclosed the purchase of ~9K shares worth ~$966K)
- TSLA +0.3% (said to be planning to invest $5 bln for Chinese factory, according to Bloomberg)
Analyst comments:
- GDS +6.2% (upgraded to Outperform from Neutral at Credit Suisse)
- FATE +4.6% (ticking higher; initiated with a Buy at Citigroup; tgt $20)
- DBX +2.7% (upgraded to Buy from Hold at Jefferies)
- PZZA +2.5% (upgraded to Buy from Hold at Jefferies)
- EA +1% (upgraded to Buy from Hold at Argus)
- FSLR +0.7% (added to Analyst Focus List at JP Morgan)
- AFL +0.5% (upgraded to Buy from Hold at Sandler O'Neill)